Method of treatment of symptoms of menopause
US12264164B2 · kind B2 · utility
0Cited by
10References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 31, 2023 |
| Grant date | Apr 1, 2025 |
| Priority date | — |
| Expiry date | Jul 31, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention generally relates to novel pharmaceutical formulations containing 2-[3,5-Bis(trifluoromethyl)phenyl]-N-{4-(4-fluoro-2-methylphenyl)-6-[(7S,9aS)-7-(hydroxymethyl) hexahydropyrazino [2,1-c] [1,4]oxazin-8(1H)-yl]-3-pyridinyl}-N,2-dimethylpropanamide, methods of preparation thereof and their use in medical therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.